Insider Transactions Reported by 23 Insiders of HAEMONETICS CORP

Symbol
HAE on NYSE
Location
Boston, MA

Insiders trading volume in the past year

HAEMONETICS CORP executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Simon President & CEO, Director $26,055,242 30 May 2025
Josep Llorens EVP, Global Manufacturing $2,961,886 28 May 2024
William Burke EVP, Chief Financial Officer $2,616,839 23 Aug 2021
Michelle L. Basil EVP and General Counsel $2,201,710 30 May 2025
James DArecca EVP, Chief Financial Officer $1,962,898 30 May 2025
Anila Lingamneni EVP, Chief Technology Officer $1,919,790 11 Jul 2024
Charles J. Dockendorff Director $1,868,308 24 Jul 2025
ROBERT E. ABERNATHY Director $1,863,832 24 Jul 2025
MARK W. KROLL Director $1,746,853 +$98,784 +6% 10 Nov 2025
CATHERINE M. BURZIK Director $1,688,493 05 Aug 2022
Stewart W. Strong President, Global Hospital $1,658,565 26 Jul 2024
Chad M. Nikel President, Global Plasma & BC $1,497,657 06 Aug 2021
Ellen M. Zane Director $1,445,419 24 Jul 2025
Laurie A. Miller SVP, Human Resources $1,444,803 17 Sep 2025
Claire Pomeroy Director $1,258,819 24 Jul 2025
MICHAEL J. COYLE Director $1,148,546 24 Jul 2025
Lloyd Emerson Johnson Director $964,931 24 Jul 2025
Roy Galvin EVP, Chief Commercial Officer $640,678 31 Oct 2025
Diane M. Bryant Director $531,670 24 Jul 2025
Dan Goldstein VP, Corporate Controller $384,176 13 Jun 2022
Jacqueline Scanlan SVP, Global Human Resources $364,220 07 Jun 2021
Frank Chan EVP, Chief Operating Officer $352,262 16 May 2025
Farris Maryanne Maunsell VP, Chief Accounting Officer $279,830 05 Jun 2025

Recent Insider Transactions by Companies or Individuals for HAEMONETICS CORP

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.